Adynxx Inc banner

Intrinsic Value

ADYX latest financial reports are more than 3 years old.
ADYX doesn't have a meaningful market cap.
Not Available for ADYX

There is not enough data to reliably calculate the intrinsic value for Adynxx Inc.

Do our valuations actually work? See backtest results .

Alternatives to ADYX

Fundamental Analysis

What Adynxx Does

Biotechnology Health Care

Adynxx, Inc. is a clinical stage biopharmaceutical company, which engages in the manufacture, development, and sale of novel, disease-modifying products for the treatment of pain and inflammation. The company is headquartered in San Francisco, California and currently employs 6 full-time employees. The firm is focused on the development of a new class of therapeutics called transcription factor decoys and bringing to market disease-modifying products to address unmet needs in the treatment of pain and inflammation.

Headquarters
United States of America US
Employees
6
IPO date
Oct 12, 1998
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Adynxx Inc

Wall St Price Targets

Capital Returns

Buyback Yield
LOCKED
Debt Paydown Yield
LOCKED

Competitive Landscape